ACAD
34.9
-0.37
-1.05%
AEMD
4.78
-0.16
-3.24%
APRI
0.43
-0.03
-6.5000%
ARNA
1.62
+0.03
+1.89%
ATEC
0.2
0.00
0.00%
CNAT
2.25
+0.01
+0.45%
CRXM
0.18
+0.01
+5.46%
CYTX
2.97
-0.06
-1.98%
DXCM
63.15
-2.17
-3.32%
GNMK
7.15
+0.03
+0.42%
HALO
9.89
-0.18
-1.79%
ILMN
143.12
-0.43
-0.30%
INNV
0.227
-0.041
-15.422%
INO
10.69
-0.47
-4.21%
ISCO
2.28
-0.02
-0.87%
ISIS
57.56
0.00
0.00%
LGND
121.96
-0.6
-0.49%
LPTN
0.173
-0.007
-4.0601%
MBVX
0.56
-0.04
-6.67%
MEIP
1.43
+0.01
+0.70%
MNOV
6.76
+0.04
+0.60%
MRTX
17.45
-0.39
-2.19%
MSTX
0.34
0.00
0.00%
NBIX
45.83
-0.73
-1.57%
NUVA
53.32
-0.48
-0.89%
ONCS
1.62
-0.02
-1.22%
ONVO
2.71
-0.07
-2.52%
OREX
0.41
-0.02
-4.25%
OTIC
14.21
-0.25
-1.73%
QDEL
16.28
-0.17
-1.03%
RCPT
231.96
0.00
0.00%
RGLS
5.77
-0.09
-1.54%
RMD
58.22
+0.5
+0.87%
SPHS
1
+0.07
+7.53%
SRNE
6.36
-0.26
-3.93%
TROV
5.35
-0.01
-0.19%
VICL
0.38
-0.01
-3.18%
VOLC
18
0.00
0.00%
ZGNX
10
-0.16
-1.57%
ACAD
34.9
-0.37
-1.05%
AEMD
4.78
-0.16
-3.24%
APRI
0.43
-0.03
-6.5000%
ARNA
1.62
+0.03
+1.89%
ATEC
0.2
0.00
0.00%
CNAT
2.25
+0.01
+0.45%
CRXM
0.18
+0.01
+5.46%
CYTX
2.97
-0.06
-1.98%
DXCM
63.15
-2.17
-3.32%
GNMK
7.15
+0.03
+0.42%
HALO
9.89
-0.18
-1.79%
ILMN
143.12
-0.43
-0.30%
INNV
0.227
-0.041
-15.422%
INO
10.69
-0.47
-4.21%
ISCO
2.28
-0.02
-0.87%
ISIS
57.56
0.00
0.00%
LGND
121.96
-0.6
-0.49%
LPTN
0.173
-0.007
-4.0601%
MBVX
0.56
-0.04
-6.67%
MEIP
1.43
+0.01
+0.70%
MNOV
6.76
+0.04
+0.60%
MRTX
17.45
-0.39
-2.19%
MSTX
0.34
0.00
0.00%
NBIX
45.83
-0.73
-1.57%
NUVA
53.32
-0.48
-0.89%
ONCS
1.62
-0.02
-1.22%
ONVO
2.71
-0.07
-2.52%
OREX
0.41
-0.02
-4.25%
OTIC
14.21
-0.25
-1.73%
QDEL
16.28
-0.17
-1.03%
RCPT
231.96
0.00
0.00%
RGLS
5.77
-0.09
-1.54%
RMD
58.22
+0.5
+0.87%
SPHS
1
+0.07
+7.53%
SRNE
6.36
-0.26
-3.93%
TROV
5.35
-0.01
-0.19%
VICL
0.38
-0.01
-3.18%
VOLC
18
0.00
0.00%
ZGNX
10
-0.16
-1.57%
Home » Archive by Category

Diagnostics

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

August 26, 2011 – 9:57 am

The Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through …

SDBN August 16th 2011 Event Featuring Pathway Genomics

July 29, 2011 – 9:41 am

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for …